Apheresis Market

Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), and Terumo BCT, Inc. (U.S) to Dominate the Global Apheresis Market

The global apheresis market is consolidated and highly competitive, with the top five players accounting for ~ 85% of the market share in 2015. In this consolidated market, Haemonetics Corporation (U.S.), Fresenius Medical Care, and Terumo BCT, Inc. are the leading players. Other players in this market include Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan). A majority of the leading players in this market are based in developed countries across North America and Europe.

The leading position of Haemonetics Corporation is attributed to its wide product portfolio in both devices and disposables segments. The company has a wide geographic presence across the U.S., Europe, Japan, and other parts of Asia, which enables it to cater to customers across the globe. Around 50% of the company’s revenue is generated from the U.S. market. The company mainly focuses on agreements and acquisitions to maintain its position in the market.

Fresenius Medical Care is another leading company in the market. This is attributed to the company’s strong presence in North America, Europe, Asia-Pacific, Latin America, and Africa. The company is also expanding its presence in the emerging markets by strengthening its business operations in those markets. In order to increase its market share and revenue, the company pursues the strategy of product launch and acquisitions.

A majority of the top players adopted product launches; acquisitions, agreements, collaborations, and partnerships; and geographic expansions as their key growth strategies. Agreements, partnerships, and collaborations were the preferred strategy adopted by key players in the global apheresis market. For instance, in December 2016, Fresenius Kabi USA and Terumo Cardiovascular Group (U.S.) entered into a five-year distribution agreement for Fresenius Kabi’s CATSmart, a continuous autotransfusion system. This agreement allowed Fresenius Kabi to meet their customers’ need for allogeneic blood transfusions. Similarly, in October 2016, Cerus Corporation (U.S.) entered into a distribution agreement with Hemolife Fundación Banco Nacional de Sangre (Colombia) to supply Cerus’s INTERCEPT Blood System to hospitals in Colombia.

Related Reports:

Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021

Contact:
Mr.Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]

Report Code
MD 1407
RI Published ON
2/20/2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Apheresis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved